Construction of a solid Cox model for AML patients based on multiomics bioinformatic analysis

Acute myeloid leukemia (AML) is a highly heterogeneous hematological malignancy. The bone marrow (BM) microenvironment in AML plays an important role in leukemogenesis, drug resistance and leukemia relapse. In this study, we aimed to identify reliable immune-related biomarkers for AML prognosis by m...

Full description

Bibliographic Details
Main Authors: Fu Li, Jiao Cai, Jia Liu, Shi-cang Yu, Xi Zhang, Yi Su, Lei Gao
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-08-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.925615/full
_version_ 1818498669459013632
author Fu Li
Jiao Cai
Jiao Cai
Jia Liu
Shi-cang Yu
Xi Zhang
Yi Su
Lei Gao
author_facet Fu Li
Jiao Cai
Jiao Cai
Jia Liu
Shi-cang Yu
Xi Zhang
Yi Su
Lei Gao
author_sort Fu Li
collection DOAJ
description Acute myeloid leukemia (AML) is a highly heterogeneous hematological malignancy. The bone marrow (BM) microenvironment in AML plays an important role in leukemogenesis, drug resistance and leukemia relapse. In this study, we aimed to identify reliable immune-related biomarkers for AML prognosis by multiomics analysis. We obtained expression profiles from The Cancer Genome Atlas (TCGA) database and constructed a LASSO-Cox regression model to predict the prognosis of AML using multiomics bioinformatic analysis data. This was followed by independent validation of the model in the GSE106291 (n=251) data set and mutated genes in clinical samples for predicting overall survival (OS). Molecular docking was performed to predict the most optimal ligands to the genes in prognostic model. The single-cell RNA sequence dataset GSE116256 was used to clarify the expression of the hub genes in different immune cell types. According to their significant differences in immune gene signatures and survival trends, we concluded that the immune infiltration-lacking subtype (IL type) is associated with better prognosis than the immune infiltration-rich subtype (IR type). Using the LASSO model, we built a classifier based on 5 hub genes to predict the prognosis of AML (risk score = -0.086×ADAMTS3 + 0.180×CD52 + 0.472×CLCN5 - 0.356×HAL + 0.368×ICAM3). In summary, we constructed a prognostic model of AML using integrated multiomics bioinformatic analysis that could serve as a therapeutic classifier.
first_indexed 2024-12-10T20:18:43Z
format Article
id doaj.art-ba22484ed7674f79b43d5ebfa5a7a41f
institution Directory Open Access Journal
issn 2234-943X
language English
last_indexed 2024-12-10T20:18:43Z
publishDate 2022-08-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Oncology
spelling doaj.art-ba22484ed7674f79b43d5ebfa5a7a41f2022-12-22T01:35:07ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2022-08-011210.3389/fonc.2022.925615925615Construction of a solid Cox model for AML patients based on multiomics bioinformatic analysisFu Li0Jiao Cai1Jiao Cai2Jia Liu3Shi-cang Yu4Xi Zhang5Yi Su6Lei Gao7Medical Center of Hematology, Xinqiao Hospital, Army Medical University, Chongqing, ChinaDepartment of Hematology and Hematopoietic Stem Cell Transplantation Centre, The General Hospital of Western Theater Command, Chengdu, ChinaDepartment of Stem Cell and Regenerative Medicine, Southwest Hospital, Army Medical University, Chongqing, ChinaMedical Center of Hematology, Xinqiao Hospital, Army Medical University, Chongqing, ChinaDepartment of Stem Cell and Regenerative Medicine, Southwest Hospital, Army Medical University, Chongqing, ChinaMedical Center of Hematology, Xinqiao Hospital, Army Medical University, Chongqing, ChinaDepartment of Hematology and Hematopoietic Stem Cell Transplantation Centre, The General Hospital of Western Theater Command, Chengdu, ChinaMedical Center of Hematology, Xinqiao Hospital, Army Medical University, Chongqing, ChinaAcute myeloid leukemia (AML) is a highly heterogeneous hematological malignancy. The bone marrow (BM) microenvironment in AML plays an important role in leukemogenesis, drug resistance and leukemia relapse. In this study, we aimed to identify reliable immune-related biomarkers for AML prognosis by multiomics analysis. We obtained expression profiles from The Cancer Genome Atlas (TCGA) database and constructed a LASSO-Cox regression model to predict the prognosis of AML using multiomics bioinformatic analysis data. This was followed by independent validation of the model in the GSE106291 (n=251) data set and mutated genes in clinical samples for predicting overall survival (OS). Molecular docking was performed to predict the most optimal ligands to the genes in prognostic model. The single-cell RNA sequence dataset GSE116256 was used to clarify the expression of the hub genes in different immune cell types. According to their significant differences in immune gene signatures and survival trends, we concluded that the immune infiltration-lacking subtype (IL type) is associated with better prognosis than the immune infiltration-rich subtype (IR type). Using the LASSO model, we built a classifier based on 5 hub genes to predict the prognosis of AML (risk score = -0.086×ADAMTS3 + 0.180×CD52 + 0.472×CLCN5 - 0.356×HAL + 0.368×ICAM3). In summary, we constructed a prognostic model of AML using integrated multiomics bioinformatic analysis that could serve as a therapeutic classifier.https://www.frontiersin.org/articles/10.3389/fonc.2022.925615/fullbioinformaticAML – acute myeloid leukaemiaprognostic modelLASSOcox regression model
spellingShingle Fu Li
Jiao Cai
Jiao Cai
Jia Liu
Shi-cang Yu
Xi Zhang
Yi Su
Lei Gao
Construction of a solid Cox model for AML patients based on multiomics bioinformatic analysis
Frontiers in Oncology
bioinformatic
AML – acute myeloid leukaemia
prognostic model
LASSO
cox regression model
title Construction of a solid Cox model for AML patients based on multiomics bioinformatic analysis
title_full Construction of a solid Cox model for AML patients based on multiomics bioinformatic analysis
title_fullStr Construction of a solid Cox model for AML patients based on multiomics bioinformatic analysis
title_full_unstemmed Construction of a solid Cox model for AML patients based on multiomics bioinformatic analysis
title_short Construction of a solid Cox model for AML patients based on multiomics bioinformatic analysis
title_sort construction of a solid cox model for aml patients based on multiomics bioinformatic analysis
topic bioinformatic
AML – acute myeloid leukaemia
prognostic model
LASSO
cox regression model
url https://www.frontiersin.org/articles/10.3389/fonc.2022.925615/full
work_keys_str_mv AT fuli constructionofasolidcoxmodelforamlpatientsbasedonmultiomicsbioinformaticanalysis
AT jiaocai constructionofasolidcoxmodelforamlpatientsbasedonmultiomicsbioinformaticanalysis
AT jiaocai constructionofasolidcoxmodelforamlpatientsbasedonmultiomicsbioinformaticanalysis
AT jialiu constructionofasolidcoxmodelforamlpatientsbasedonmultiomicsbioinformaticanalysis
AT shicangyu constructionofasolidcoxmodelforamlpatientsbasedonmultiomicsbioinformaticanalysis
AT xizhang constructionofasolidcoxmodelforamlpatientsbasedonmultiomicsbioinformaticanalysis
AT yisu constructionofasolidcoxmodelforamlpatientsbasedonmultiomicsbioinformaticanalysis
AT leigao constructionofasolidcoxmodelforamlpatientsbasedonmultiomicsbioinformaticanalysis